![Embracing diversity many people linked together](/sites/default/files/styles/x_large/public/2024-09/Embracing-diversity.jpg?itok=r6TDaw_3)
Embracing diversity in psychiatry and neurology clinical tri...
There is broad recognition of the need to promote diversity and inclusion in clinical trials, with the goal of improving health equity and enhancing the validity and generalisability of stu
![Nucala](/sites/default/files/styles/x_large/public/2024-09/nucala.jpg?itok=FxYXQs07)
GSK says Nucala hits the target in new COPD trial
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<
![Hand holding a pen following the peaks and troughs of a graph on screen](/sites/default/files/styles/x_large/public/2024-09/funding.jpg?itok=RRDnZHZy)
BioAge's $100m IPO, and other biotech financings
Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable privat
![Genetic Leap image of Genetic Intelligence](/sites/default/files/styles/x_large/public/2024-09/Genetic_leap_AI_stacks.jpg?itok=KcBn623s)
Lilly adds to genetic meds push with Genetic Leap alliance
In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted t
![Lykos Therapeutics' CEO Amy Emerson, who has stood down](/sites/default/files/styles/x_large/public/2024-09/amy-emerson-headshot.jpg?itok=o10Gicz6)
Lykos CEO steps down after MDMA is rejected by FDA
The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
![PM Society interactive face to face session](/sites/default/files/styles/x_large/public/2024-09/Interactive-session-2.jpg?itok=IQkoLRWY)
PM Society’s sixth Careers Event – 26th February 2025
For the sixth year running the PM Society will be bringing their ‘A Career in Pharmaceutical and Healthcare Communications’ event back to the Royal Society of Medicine.
![Complex Bioengineering for Cell Therapies Summit banner image](/sites/default/files/styles/x_large/public/2024-09/Complex-Bioengineering-for-Cell-Therapies-Summit-.jpg?itok=PSC61WS7)
Complex Bioengineering for Cell Therapies Summit
Unravel Complex TME Biology, Optimize Payload Delivery, & Overcome Early Risks in Developing Advanced Logic Gated & Dual-Targeted Cell Therapies
![4th annual Rare & Genetic Kidney Disease Drug Development Summit](/sites/default/files/styles/x_large/public/2024-09/R%26G-pharmaphorum.jpg?itok=Tx6AUtO1)
4th annual Rare & Genetic Kidney Disease Drug Development Su...
Uncover Disease Pathophysiology, Clarify Response Biomarkers, Leverage Electronic Health Records & Implement Patient-Centric Recruitment Strategies to Accelerate Game-Changing Therapies
![15th World ADC San Diego 2024 banner](/sites/default/files/styles/x_large/public/2024-08/World-ADC-San-Diego-pharmaphorum.jpg?itok=A6QV3yAy)
15th World ADC San Diego 2024
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
![LEAP HR: Emerging Biopharma banner](/sites/default/files/styles/x_large/public/2024-08/LEAP-HR-Emerging-Biopharma-banner.jpg?itok=z-SQ2Fr1)
LEAP HR: Emerging Biopharma
Lead The Future in Emerging Biopharma: Revolutionize Your HR Strategy, Develop Top Talent & Empower Your Team to Secure Success Amidst Industry Turbul